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Abstract: Background: Smoking is a major health-related problem in Jordan due to which an 
effective smoking cessation program is needed. Lung Age which emphasizes the concept of a 
premature aging of the lungs, is a simple notion that smokers can grasp. Employing reference lung 
age equations can help health care providers convince smokers to quit. In this study the applicability 
of reference equations was assessed in estimating lung age for the Jordanian population, to aid 
smoking cessation.  
Methods: Adult Jordanians were recruited from Al-Zaytoonah University of Jordan and from several 
community pharmacies, polyclinics and hospitals located in different areas in Jordan. Overall, 1767 
participants of both genders from different age groups were recruited to evaluate the applicability of 
different reference lung equations for the Estimated Lung Age (ELA). SPSS was used to conduct all 
statistical analysis.  
Results: A paired t-test showed a significant difference (p<0.05) between the Chronological Lung 
Age (CLA) and the ELA among the non-smokers. Similarly, some reference equations including 
Hansen and Morris and Temple FEF25-75 equations failed to show significant differences in ELA-
CLA between different smoking status groups for women.  
Conclusions: Our results suggest that the current lung age equations are not reliable in predicting 
lung age among the Jordanian population, and thus cannot be used in smoking cessation programs. 
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1. INTRODUCTION 
Smoking in Jordan has a high prevalence; according to a 
study conducted in 2014, 32.3% of the respondents reported 
being current smokers (54.9% of males and 8.3% of 
females), and only 2.9% were ex-smokers [1]. In addition 
there has been a recent increase in the use of water pipes [2, 
3], particularly among young people and females. A survey 
that enrolled 1000 students (grades 6, 8, 10 and 12) found 
that 36% of the youth have tried water-pipe smoking, 36% of 
them were males and 64% were female [2]. In addition, there 
has also been a recent increase in the use of electronic 
cigarettes [4]. Therefore, it is for healthcare professionals to 
help persuade cigarette smokers to quit smoking and so 
reduce ill health and premature deaths [5]. Indeed, promoting 
behavioral changes, including smoking cessation should be  
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an essential component of strategies that reduce disease risk 
factors.  
Motivating people to quit smoking is the major goal in 
smoking cessation programs. Quit rates were shown to be 
improved within participants that were given feedback using 
biomarkers related to the detrimental effect of smoking, 
including arterial damage, spirometry and exhaled carbon 
monoxide [6]. Spirometry is a noninvasive, easily performed 
and inexpensive test that offers diagnostic insight into the 
type and the extent of lung function impairment [7]. 
Spirometry also helps monitor the prognosis of lung disease 
and response to treatments [7]. The forced expiratory volume 
in one second (FEV1), due to its ease of measurement and 
good reproducibility, is the most widely used lung function 
parameter in clinical practice and research [8]. In 1977, the 
landmark study by Fletcher and Peto [9] found an annual 
decline in FEV1 with age which increased in the presence of 
other factors including smoking. Later, several studies 
showed that a low value of FEV1 is an independent predictor 
and a powerful marker of increased risk of Chronic 
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Obstruction Pulmonary Disease (COPD), lung cancer, 
cardiovascular disease, and premature death [9, 10]. 
Smoking has been shown to accelerate the decline in FEV1, 
but this effect is modifiable, and can be attenuated by 
smoking cessation [11].  
In the light of increased prevalence of smoking, and as 
smoking is the most important preventable risk factor in 
mortality rates, several smoking cessation programs were 
initiated. One approach used the ‘accelerated decline in 
FEV1’ as a tool to help smokers quit, thus the ‘lung age 
concept’ was coined [12]. Taking into account patient age, 
sex, height and ethnicity, the ‘estimated lung age’ of an 
individual can be defined as the age at which the measured 
FEV1 matches the predicted value of a healthy non-smoker 
[12]. Morris and Temple (1985) were the first to introduce 
this concept. They estimated lung age from the equations 
formulated to predict FEV1 [12]. This was made to simplify 
interpretation of the spirometric test results and turn it into a 
powerful and clear message that can be delivered to patients. 
The key message is that smokers’ lung age is older than their 
chronological age. This information could therefore be used 
to warn smokers of the pulmonary impairment caused by 
smoking, with the intention of generating a strong stimulus 
to quit smoking [12]. Indeed, previous work has found that 
informing smokers of their lung age, obtained from the 
spirometric lung function, led to increased quit rates [12, 13]. 
A study that compared participants enrolled in a smoking 
cessation program who were informed of their lung age and 
those enrolled in the same program but were not informed 
found significant differences in the number who remained as 
nonsmokers after 12 months (13.6% versus 6.4% 
respectively). However, before considering utility of the lung 
age concept in Jordan, and in accordance with the American 
Thoracic Society guidelines which recommend that 
predictive equations should be derived from a ‘relevant’ 
population and should be updated every 10 years [14], it is 
required to test its applicability to the Jordanian population. 
Furthermore, several different reference equations are used 
to predict lung age in the worldwide population [7, 12, 15-
19]. The aim of this study is to test the applicability of the 
previously published Estimated Lung Age (ELA) reference 
equations in the Jordanian population.  
2. MATERIAL AND METHODS 
2.1. Participants and Recruitment 
This multi-center cross-sectional study examined the 
applicability of the ELA equation on Jordanian adults. 
Participants were approached in AlZaytoonah University of 
Jordan (including students, teaching and administrative staff) 
and in several pharmacies and polyclinics and hospitals from 
different locations in Jordan, including the capital city 
Amman as well as Madaba, Zarqa, Fuheis and Irbid (major 
cities in Jordan). Advertisements were placed on the internet 
and in places where participant recruitment was conducted, 
then a personal approach was used to invite healthy 
participants who accompanied the patients were asked to 
consider participation. If they agreed, they were presented 
with study information and then if they wished to proceed 
were consented (more detailed information about centers and 
number of recruits at each city is located in the appendix, 
Fig. 1 and Table 8). Following recruitment, a unique 
identifier code was used for each participant. Participants 
were divided into three groups: current smokers, ex-smokers 
and lifelong nonsmokers.  
The inclusion criteria consisted of Jordanian adult, no 
history of respiratory chronic diseases or recent respiratory 
infections, and no cardiovascular diseases. Exclusion criteria 
consisted of inability to perform the spirometry tests 
successfully (shallow or short inhalation, short exhalation, or 
coughing during the test led to participate exclusion), aged 
younger than 18, presence of respiratory or cardiovascular 
problems. In addition, participants with body mass index 
(BMI) equal to or higher than 35 were excluded due to the 
effect of accumulated fat in the abdominal region on 
ventilatory mechanics [20, 21].  
2.2. Data Collection 
The weight and height of each participant was measured 
before the participants performed the test. An explanation of 
the spirometry test was conveyed by a certified technician.  
Participants were given a questionnaire and a consent 
form. The consent form included a short summary of the 
study and its objectives, and the questionnaire included 
questions about medication use, smoking habits and health 
status, including incidence of asthma and other pulmonary 
diseases. Ethical approval was granted by the Ethical 
Committee of AlZaytoonah University, Amman, Jordan. 
2.3. Measurement of Pulmonary Function 
Spirometry tests were performed according to the 
European Respiratory Society (ERS) guidelines [22]. The 
tests were performed using a computer-based spirometer 
(MIR-Minispir New). The same spirometer was used by the 
same researcher for all tests and participants. Each 
participant was asked to take a deep breath and then blow out 
as strong and as fast as they could for at least 6 seconds until 
complete exhalation was performed. Nose clips were used to 
avoid any air leakage and a disposable turbine was used for 
each participant to preserve high hygiene conditions and 
prevent any spread of infection. Participants were told to seal 
their lips around the turbine before blowing out. The test was 
repeated three times and the best reading was recorded. 
Forced expiratory volume in the first second (FEV1), forced 
vital capacity (FVC), forced expiratory rate (FEV1/FVC* 
100), forced expiratory flow over the middle one half of the 
FVC(FEF25-75) and peak expiratory flow rate (PEFR) were 
measured. Acceptable maneuvers were achieved when the 
difference between the largest and the next largest FVC was 
≤ 0.15L and the difference between the largest and next 
largest FEV1 was ≤ 0.15L. In PEFR, in adherence with ERS 
guidelines, the highest reading out of three acceptable 
readings was recorded.  
2.4. Measurement of Anthropometric Parameters 
Weight was measured to the nearest 0.1 kg using a 
standardized electronic weighing machine, with the 
participants standing without footwear and wearing light 
clothes. The height of participants was measured with a 
stadiometer, to the nearest centimeter. Body mass index 
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(BMI) was calculated by using Quetlet’s index (body weight 
in kg/height in m2 [23]. 
2.5. Statistical Analysis 
ELA was calculated for each participant using different 
reference equations including those developed by Morris and 
Temple [12], Hansen. [19], Newbury [18], and Ben Saad 
[17]. Equations that were based on a non-Caucasian 
population were excluded. The frequency and percentage of 
participants whose ELA was below zero or over 110 years 
for each lung age equation for each group were evaluated 
according to a previous work [15]. The frequency and 
percentage of participants with ELA “clinically and 
significantly” [15] higher than the CLA for each lung age 
equation for each group was determined.  
ELA was considered as “clinically and significantly” 
higher than the CLA, when the difference between the ELA 
and CLA is higher than the 13.4 years in men or 15.0 in 
women [15]. Paired t-tests were performed to compare the 
mean of the CLA with the mean of the ELA produced by 
each lung age equation for each group. Delta ELA-CLA was 
compared between the three smoking groups using analysis 
of covariance (ANCOVA). If the assumptions for running 
ANCOVA were not met Quade's rank analysis of covariance 
was used. Data were analysed with the Statistical Package 
for Social Sciences (SPSS) version 23 (Chicago, Illinois) 
[24]. 
3. RESULTS 
3.1. Demographic Characteristics  
A total of 1863 participants met the inclusion criteria and 
agreed to enroll. Of these, 96 were unable to complete the 
pulmonary function test (PFT) successfully; therefore, the 
studied participants included 1767 who were qualified for 
the study analysis. The demographics of the study 
participants are displayed in Table 1. Just over half of the 
participants were male (55.1%). Most participants were 
classified as having normal weight or were overweight 
(40.4% and 37.4% respectively), although the inclusion 
criteria included BMI to be equal to or less than 35. About a 
third of the study sample was between the ages of 18 to 24, 
however, all age groups above 18 were represented in the 
study (Table 1). Around half of the participants were lifelong 
non-smokers (51.7%); only 9.6% were ex-smokers.  
Table 1. Demographics of the participants. 
 
Variable n (%) 
Gender 
Male 973 (55.1) 
Female 794 (44.9) 
Obesity Status* 
Underweight 26 (1.5) 
Normal weight 714 (40.4) 
Overweight 661 (37.4) 
Obese 366 (20.7) 
Age Group 
18-24 593 (33.6) 
25-29 209 (11.8) 
30-39 330 (18.7) 
40-49 318 (18.0) 
50-59 188 (10.6) 
60-69 101 (5.7) 
Above 70 28 (1.58) 
Smoking Status 
Smoker 684 38.7 
Ex-smoker 169 9.6 
Non-Smoker 914 51.7 
*Body mass index (BMI) was calculated by using Quetlet’s index (body weight in kg/height in m2 [21].  
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3.2. Lung Age 
PFT chronological age (CLA) as well as estimated lung 
age (ELA) were calculated by different reference equations 
for all participants (see Table 2). Results are shown for the 
smokers, ex- smokers and non-smokers. Furthermore, results 
are presented for male and female participants.  
3.3. Number of Participants with Abnormal ELA  
Number and proportion of healthy Jordanian participants 
with ELA "clinically and significantly" higher than CLA 
(Table 3) which was calculated based on previous work [15]. 
The percentage within male smokers, ex-smokers and non-
smokers varied from as high as 60.4%, 63.0% and 48.4 % 
respectively (when using Newbury. equation) to 18.5%, 
17.3% and 9.35 % respectively (using Morris and Temple 
equation using FEV1) for the smoker and ex-smoker, and 
(Ben Saad for the non-smoker). For female participants the 
percentage for smokers, ex-smokers and non-smokers who 
had ELA "clinically and significantly" higher than CLA 
reached as high as 64.2%, 92.9% and 54.6% respectively 
(using Ben Saad. equation), while the lowest percentages 
were 13.5%, 14.3% and 8.4% respectively (using Hansen. 
equation for smokers and ex-smokers and Morris and 
Temple equation using FEV1 for the non-smoker).  
Combining all participants, the highest percentages of 
participants who had ELA "clinically and significantly" 
higher than CLA in the smokers, ex-smokers and non-
smokers were 58.0%, 63.9% and 39.3% respectively (using 
Newbury. equation for smokers and ex-smokers and Ben 
Saad. equation for non-smokers), while the lowest 
percentages were 17.7%, 14.8% and 9.7% respectively 
(using Morris and Temple equation using FEV1 for the 
Table 2. Pulmonary function test (PFT) and Estimated Lung Age (ELA) calculated by different equations (numbers represent 
mean ± SD). 
 
 
Male Female All Participants 
Smoker 
N=536 
Ex-smoker 
N=127 
Nonsmoker 
N=310 
Smoker 
N=148 
Ex-Smoker 
N=42 
Non-Smoker 
N=604 
Smoker 
N=684 
Ex-Smoker 
N=169 
Non-Smoker 
N=914 
FEV1 
4.05 ±  
0.83 
3.84 ±  
0.69 
4.10 ±  
0.84 
2.90 ±  
0.59 
3.00 ±  
0.43 
2.79 ±  
0.54 
3.80 ±  
0.92 
3.64 ±  
0.73 
3.23 ±  
0.93 
FVC 
4.87 ±  
0.91 
4.69 ±  
0.82 
4.91 ±  
0.97 
3.42 ±  
0.65 
3.42 ±  
0.59 
3.31 ±  
0.59 
4.56 ±  
1.05 
4.38 ±  
0.95 
3.85 ±  
1.099 
FEF2575 
3.98 ±  
1.25 
3.79 ±  
1.34 
3.95 ±  
1.20 
3.13 ±  
0.90 
3.68 ±  
0.81 
2.81 ±  
0.91 
3.79 ±  
1.24 
3.76 ±  
1.22 
3.17 ±  
1.22 
FEV1/FVC% 
83.14 ±  
7.18 
81.94 ±  
6.0 
83.51 ±  
6.63 
84.82 ±  
6.38 
88.39 ±  
7.13 
84.33 ±  
6.41 
83.51 ±  
7.04 
83.54 ±  
6.88 
84.05 ±  
6.75 
Height 
1.75 ±  
0.07 
1.74 ±  
0.058 
1.74 ±  
0.07 
1.61 ±  
0.06 
1.62 ±  
0.06 
1.59 ±  
0.05 
1.72 ±  
0.09 
1.71 ±  
0.08 
1.64 ±  
0.09 
BMI 
27.53 ±  
4.95 
26.58 ±  
5.13 
26.43 ±  
5.34 
27.58 ±  
5.38 
24.04 ±  
5.03 
25.01 ±  
4.33 
27.55 ±  
5.04 
25.95 ±  
5.21 
25.49 ±  
4.74 
Chronological Age 
33.91 ±  
12.32 
36.79 ±  
17.46 
36.51 ±  
14.85 
33.03 ±  
10.77 
25.05 ±  
8.18 
36.87 ±  
14.96 
33.72 ±  
12 
33.87 ±  
16.46 
36.75 ±  
14.92 
Morris & Temple 
FVC 
43.47 ±  
32.30 
47.81 ±  
30.47 
40.35 ±  
33.29 
42.12 ±  
22.76 
43.61 ±  
21.12 
43.71 ±  
21.41 
43.18 ±  
30.48 
46.76 ±  
28.43 
42.57 ±  
26.08 
Morris & Temple 
FEV1 
31.80 ±  
23.91 
36.97 ±  
20.63 
29.68 ±  
23.41 
31.95 ±  
20.29 
29.03 ±  
14.59 
34.09 ±  
19.01 
31.83 ±  
23.16 
34.99 ±  
19.58 
32.6 ±  
20.7 
Morris & Temple 
FEF2575 
39.27 ±  
27.27 
43.03 ±  
29.65 
39.71 ±  
26.07 
40.51 ±  
28.15 
22.87 ±  
27.14 
49.7 ±  
28.87 
39.55 ±  
27.45 
37.65 ±  
30.26 
46.51 ±  
28.37 
Newbary 
50.91 ±  
25.59 
56.09 ±  
22.30 
48.43 ±  
24.89 
46.43 ±  
15.93 
44.25 ±  
11.64 
47.81 ±  
15.06 
49.94 ±  
23.89 
53.15 ±  
20.8 
48.02 ±  
18.96 
Hansen 
32.09 ±  
23.22 
35.42 ±  
35.37 
32.54 ±  
22.63 
32.30 ±  
20.60 
20.04 ±  
21.79 
35.75 ±  
25.56 
32.14 ±  
22.66 
31.6 ±  
33.15 
34.66 ±  
24.64 
Ben Saad 
36.27 ±  
16.84 
38.75 ±  
14.74 
33.85 ±  
16.09 
50.93 ±  
4.23 
50.78 ±  
3.1 
52.09 ±  
4.13 
39.44 ±  
16.2 
41.74 ±  
13.88 
45.9 ±  
13.17 
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smoker and non-smoker and Hansen. equation for the ex-
smoker). 
3.4. Comparing ELA Calculated from Different 
Reference Equations with CLA 
Paired sample t-tests were conducted to compare ELA 
data calculated from different equations with CLA in males 
and females (see Tables 4 and 5, respectively). In the males, 
statistically significant differences were shown between ELA 
and CLA when using Morris and Temple equation using 
FVC, Morris and Temple equation using FEF2575, Newbury 
and Ben Saad in smokers, while statistical significant 
differences were shown using Morris and Temple equation 
using FVC and Newbury in ex-smokers. Moreover, 
significant differences were shown between Morris and 
Temple equation using FVC, Morris and Temple equation 
using FEV1, Newbury, Hansen and Ben Saad in non-
smokers (Table 4). 
In females, significant differences were shown between 
Morris and Temple equation using FVC, Morris and Temple 
equation using FEF2575, Newbury, Hansen and Ben Saad in 
smokers. In addition, significant differences were shown 
between Morris and Temple equation using FVC, Newbury, 
and Ben Saad in ex-smokers. Furthermore, significant 
differences were shown between Morris and Temple 
equation using FVC, Morris and Temple equation using 
FEV1, Morris and Temple equation using FEF2575, 
Newbury and Ben Saad in non-smokers (Table 5). 
Table 3. Estimated Lung Age “clinically and significantly” higher, numbers represent mean (SD). 
 
Equation 
Male Female All Participants 
Smoker 
N=536 
Ex-smoker 
N=127 
Nonsmoker 
N=310 
Smoker 
N=148 
Ex-
Smoker 
N=42 
Non-
Smoker 
N=604 
Smoker 
N=684 
Ex-
Smoker 
N=169 
Non-
Smoker 
N=914 
Hansen. 
105 
(0.2) 
19 
(0.15) 
35 
(0.11) 
20 
(0.14) 
6 
(0.14) 
58 
(0.1) 
125 
(0.18) 
25 
(0.15) 
93 
(0.1) 
Newbury. 
324 
(60.4) 
80 
(63) 
150 
(48.4) 
73 
(49.3) 
28 
(66.7) 
192 
(31.8) 
397 
(58) 
108 
(63.9) 
342 
(37.4) 
Morris & Temple 
FEV1 
99 
(18.5) 
22 
(17.3) 
38 
(12.3) 
22 
(14.9) 
22 
(14.9) 
51 
(8.4) 
121 
(17.7) 
34 
(20.1) 
89 
(9.7) 
Morris & Temple 
FVC 
258 
(48.20) 
60 
(47.20) 
128 
(41.30) 
63 
(42.60) 
27 
(64.30) 
188 
(31.10) 
321 
(47.00) 
87 
(51.50) 
316 
(34.60) 
Morris & Temple 
FEF2527 
122 
(54.50) 
45 
(20.10) 
57 
(25.40) 
43 
(15.10) 
11 
(3.90) 
231 
(81.10) 
165 
(32.40) 
56 
(11.00) 
288 
(56.60) 
Ben Saad 
107 
(66.90) 
24 
(15.00) 
29 
(18.100) 
95 
(20.50) 
39 
(8.40) 
330 
(71.10) 
202 
(32.40) 
63 
(10.10) 
359 
(57.50) 
 
Table 4. Paired t test comparing estimated lung age calculated from different equations with chronological lung age in all smoking 
status in males. 
 
Equation 
Smoker Ex-Smoker Non-Smoker 
Mean ± SD t P Mean ± SD t P Mean ± SD t P value 
Morris & Temple 
FVC 
-9.56 ± 28.29 -7.82 <0.01 
-11.02 ± 
26.96 
-4.61 <0.01 -3.84 ± 9.32 -2.306 0.022 
Morris & Temple 
FEV1 
2.12 ± 19.96 2.46 0.01 -0.18 ± 16.73 -0.12 0.904 6.82 ± 19.20 6.26 <0.01 
Morris & Temple 
FEF2575 
-4.32 ± 22.75 -3.58 <0.01 -6.01 ± 21.59 -2.92 0.004 -1.58 ± 20.18 -1.149 0.25 
Newbury10 -17 ± 21.56 -18.25 <0.01 
-19.30 ± 
17.77 
-12.24 <0.01 
-11.91 ± 
20.49 
-10.237 <0.01 
Hansen 1.82 ± 20.53 2.06 0.04 1.364 ± 30.96 0.50 0.62 3.97 ± 18.81 3.715 <0.01 
Ben Saad -2.35 ± 14.46 -3.77 <0.01 -1.95 ± 15.05 -1.47 0.145 2.66 ± 14.034 3.341 0.001 
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Table 5. Paired t test comparing estimated lung age calculated from different equations with chronological lung age in all smoking 
status in females. 
 
Equation 
Smoker Ex-Smoker Non-Smoker 
Mean ± SD t P Mean ± SD t P Mean ± SD t P value 
Morris & Temple 
FVC 
-9.09 ± 20.92 -5.288 <0.01 -18.55 ± 21.87 -5.499 <0.01 -6.84 ± 19.50 -8.62 <0.01 
Morris & Temple 
FEV1 
1.07 ± 16.91 0.77 0.443 -3.98 ± 14.43 -1.787 0.081 2.78 ± 14.67 4.66 <0.01 
Morris& Temple 
FEF2575 
-6.57 ± 24.10 -2.82 0.006 1.60 ± 26.83 0.377 0.708 -10.35 ± 19.68 -11.23 <0.01 
Newbury10 -13.40 ± 13.40 -12.169 <0.01 -19.20 ± 12.10 -10.278 <0.01 -10.94 ± 12.76 -21.06 <0.01 
Hansen 0.72 ± 17.288 0.512 0.61 5.00 ± 20.48 1.583 0.121 1.12 ± 20.21 1.36 0.173 
Ben Saad -17.90 ± 9.58 -22.729 <0.01 -25.74 ± 8.355 -19.971 <0.01 -15.21 ± 12.71 -29.42 <0.01 
 
Table 6. ANCOVA comparing the CLA-ELA between different smoking status (numbers represent mean (SD)). 
 
 
Males* 
Smoker Ex-Smoker Non-Smoker 
Morris & Temple FEV1 
Adjusted Mean (SE) 
Mean Differences 
 
-2.18(0.84) 
4.56# 
 
0.274(1.716) 
7.02# 
 
-6.748(1.1) 
 
Newbury 
Adjusted Mean (SE) 
Mean Differences 
 
16.9(0.9) 
5.07# 
 
19.3(1.8) 
7.39# 
 
11.9(1.18) 
 
Ben Saad 
Adjusted Mean (SE) 
Mean Differences 
 
1.94(0.59) 
4.12# 
 
2.54(1.21) 
4.72# 
 
-2.18(0.77) 
 
*Age adjusted for 35.11,. # Significant at P<0.05 
 
3.5. Comparing ELA- CLA among Different Smoking 
Status 
ANCOVA assumptions were only met in the Newbury, 
Ben Saad, Morris & Temple FEV1 equations in males. 
Therefore, Quade's rank analysis of covariance was used in 
females and the rest of the equations in males. The one-way 
ANCOVA was conducted to determine differences between 
CLA and ELA on smoking status (controlling for age) where 
assumptions were met. The Morris and Temple equation 
using FEV1 showed a statistical significance within smokers, 
ex-smokers in males. Using the Newbury et al equation 
showed a statistical significance difference within smokers, 
ex-smokers in males. Finally, the Ben Saad et al. equation 
showed a statistical significance within smokers and ex-
smokers in males (Table 6). Quade's rank analysis of 
covariance showed significant differences between the 
different smoking status groups in all the studies equations 
except for Hansen and Morris and Temple FEF2575 
equations on Females (Table 7). 
4. DISCUSSION 
To the best of our knowledge, this study is the first to 
evaluate the applicability of the published spirometric 
reference equations for the ELA [12, 17-19] among the 
Jordanian population. It represents novel results comparing 
the CLA with ELA; results that may play a crucial role in 
convincing smokers of the importance of quitting this 
harmful habit.  
Pulmonary function is known to vary between ethnic 
groups [15, 22, 25]. Hence, ELA reference equations based 
on American [12, 19], South Australian [18], or North 
African populations [17] cannot readily be used on the 
Jordanian population and potentially throughout the middle 
east. Additionally, one of the drawbacks of Morris and 
Temple equation is having 20-45% of non-Caucasian origin 
[12].  
The reference equations should be derived from a 
"representative" population and should be updated at least 
every 10 years as per spirometry guidelines [22]. Similarly, 
these recommendations should be based on ELA reference 
equations. Morris and Temple’s ELA reference equations 
[12] were formulated depending on the predictive equations 
[26] that are more than 40 years old. Furthermore, Hansen.’s 
equation [19] was developed from the results of the Third 
National Health and Nutrition Examination Survey 
(NHANES-3) data that were collected between 1988 and 
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1994, and are now more than 20 years old. Demographic and 
environmental differences can result in a difference between 
a 30-year-old today and someone of the same age 40 years 
ago according to a cohort effect [14]. In addition, the use of 
outdated technology can produce inaccurate results. The use 
of old data for the creation of the ELA reference equation 
may be in part the reason for the diverging results found in 
our study. 
It is noteworthy that the methods of ELA reference 
equations generation proposed in the previous studies may 
have some mathematical and statistical flaws. The need to 
establish a reliable method to estimate spirometric lung age 
is essential [27, 28]. Morris and Temple did not provide full 
detail of their method which may be a cause of some of the 
difference between their results and ours [12]. Additionally, 
Newbury. used the population mean to estimate lung age 
[18], which might lead to difficulty in estimating the lung 
age in individuals. Indeed, in our study, a large standard 
deviation was found in ELA for non-smokers and for 
smokers when analysis was based on from Newbury.'s 
equation [18]. Conversely, Hansen. presented a logical 
fallacy in which the equations proposed predict the actual 
mean age of the participants from whom they were derived 
[19].  
In this report, ELA was estimated for 1767 healthy adult 
participants using equations developed by Morris and 
Temple [12], Newbury. [18], Hansen. [19] and Ben Saad 
[17]. Statistically significant differences in ELA results were 
demonstrated for the same participant when different 
reference equations were applied, both for males and 
females. Differences in results appeared even amongst the 
different equations of Morris and Temple’s equations [12]. A 
significant difference between the CLA and the ELA among 
non-smokers in both males and females was also evident. 
Indeed, some of the equations calculated lung ages 
significantly higher than the chronological one among the 
healthy group; including the Morris and Temple FVC-based 
equation [12] and Newbury equation [18] in males, as well 
as the Morris and Temple FVC-based and FEF2527 based 
equations [12], and the Ben Saad. [17] and Newbury 
equations [18] in females. Moreover, upon calculating lung 
age for the participants, a discrepancy in the results was 
shown with a lung age above 110 or below zero; this was 
evident across the different reference equations. Indeed, 
within male participants, the highest percentage for above 
110 years in smokers, ex-smokers and non- smokers was 
given using the Morris and Temple equation using FEV1. 
While, in female participants the highest percentage above 
110 years for ex-smokers and non- smokers was given 
through Morris and Temple equation using FEV1 and 
Hansen ’s equation. Combining all participants, the highest 
percentage for above 110 years was shown in Morris and 
Temple’s equation using FEV1. The highest percentage for 
below zero in male smokers, ex-smokers and non- smokers 
was given using Hansen. for the smokers and ex-smokers 
and Morris and Temple equation using FEV1 for ex-smokers 
and non-smokers. In female participants the highest 
percentage for below zero in smokers, ex-smokers and non- 
smokers was given using Hansen. Combining all 
participants, the highest percentage for below zero was 
shown in Hansen. No equation gave a zero percentage for 
above 110 years and the lower than zero in male and female 
participants simultaneously. 
Results also showed that ELA predicted by Morris and 
Temple [12], Ben Saad [17], and Newbury [18] equations 
was significantly higher in ELA-CLA in smokers when 
compared with the non-smoker and the lifelong non-smoker 
groups in males. Conversely, significant differences were not 
found between smokers, ex-smokers and non-smoker groups 
in females using Morris and Temple FEF25-75 [12] and 
Hansen [19] equations. Thus, these results contradict 
previous findings related to the deteriorating effect of 
smoking on lungs. These findings also suggest that the 
existing lung age equations are not reliable in predicting lung 
age among a Jordanian population and thus cannot be used 
accurately in order to promote smoking cessation. 
The discrepancy in the ELA among the non-smokers 
shown in this study might be due to the limited methodology 
used in previous studies [17]. A large percentage of the 
population sourced for this study was selected from 
participants that underwent general health screening 
examination as well as any participants accompanying them 
in various clinics and hospitals spread all around Jordan, 
parallel to study design in previous reports [15, 17]. In 
contrast to previous studies that published ELA reference 
equations, in which the sample selection was not a random 
population [12, 17-19], ours was a random sample. Several 
pharmacies, clinics and hospitals in different locations in 
Jordan were involved in recruiting volunteers which 
providing a reasonable degree of confidence in the 
generalizability of the results to the wider Jordanian 
population. The sample size required to confirm the 
Table 7. Quade's rank analysis of covariance comparing the CLA-ELA between different smoking status. 
 
Equation 
Males Females 
F P Value F P Value 
Morris & Temple FVC 4.9 <0.01 6.53 <0.01 
Morris & Temple FEV1` N/A N/A 5.51 <0.01 
Newberry N/A N/A 6.90 <0.01 
Ben SAAD N/A N/A 3.93 <0.01 
Morris & Temple fef2527 3.85 0.02 0.74 0.48 
Hansen 3.43 0.03 2.06 0.13 
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reference equations and to minimize the possibility of Type I 
or Type II errors due to sampling was found to be at least 
150 male and 150 female participants [29]. In this study, the 
sample size that was used in the calculations was 1767 
participants divided according to gender into 973 males and 
794 females. Consequently, the sample size involved in this 
study is adequate and is actually higher than the sample size 
of numerous previous similar studies that were conducted in 
more populated countries (e.g. n= 125 (18), n= 540 [17] and 
n= 988 [12]). Furthermore, the calculations Similar 
percentages for male and female participants were used in 
this study (55.1% and 44.9% respectively) analogous to 
previously published studies [12, 18, 19] but in contrast to 
the studies that had the females dominating the sample [15, 
17]. Furthermore, Hansen. formulated one equation [19] for 
both genders which contradicts prior work that has found a 
variation between the two genders in FEV1/FVC [30].  
The sample used in this study was stratified into ages 18-
24, 25-29 and then 10-year age bands for older ages. The 
sample showed a skewed to the right in age with over 30% 
of the participants being in the youngest age bracket. 
Although this was equivalent to previous work [18], the 
sample size of this study is much larger (1767 versus 988). 
The differences in the sample size and the gender 
representation among the samples may explain in part some 
of the differences in the results. 
A representative sample of healthy volunteers was 
recruited into this study to perform the spirometric 
measurement, which is essential for the success of these 
types of studies [15]. This was not the case in previously 
conducted research. More than half of the participants in a 
previous study were selected from two church groups in rural 
USA, within those groups tobacco smoking, alcohol and 
caffeine intake were prohibited while a vegetarian diet was 
supported [12]. Another study chose the population from a 
broad rural community in South Australia focusing on the 
non-smokers with no history of lung disease [31]. A more 
recent study from South Australia recruited participants from 
three locations: in the first location, participants maintained a 
high level of fitness and had frequent occupational exposure 
to smoke while fighting fires and in the second location, 
participants were exposed to industrial and traffic pollution. 
The latter location revealed a significantly higher prevalence 
of COPD and lung cancer compared to other towns in 
Australia (which the authors associated with elevated levels 
of air pollution) [18]. Another study recruited participants 
from those undergoing general health screening examination 
in only one part of the country, such as at a Japanese health 
care center [15] or at a single hospital in Tunisia [17]. These 
samples [12, 15, 17, 18, 29] cannot be described as represen-
tative of a "normal" population or even a representative of a 
normal population within the ethnic group.  
Another point of strength of the current study is that 
international guidelines definitions were used to identify the 
inclusion and non-inclusion criteria in this study for 
"healthy" adults [14, 26] as recommended in epidemiological 
studies. Moreover, recent international guidelines [15, 20, 25] 
for spirometry measurements were also employed [15, 17].  
Recommendations for respiratory testing equipment and 
procedures have been frequently updated by the ATS/ERS 
[15, 22, 25]. Accordingly, spirometer reference equations 
should be implemented for a population using equivalent 
instruments and testing procedures [15, 22, 25]. Previous 
studies used different equipment, including Stead-Wells and 
dry rolling-seal spirometers [12, 19] or outdated testing 
procedures [18] that can provide different results to those 
currently recommended by the ATS [32]. This study 
followed the most recent ATS/ERS spirometry guidelines 
[15, 22, 25] as recommended by previous reports [15].  
Previous studies have included only one lung function 
test, mainly the FEV1, in reference equations with a different 
model for each gender [12, 18]. Another study used FEV1/ 
FVC [19], which was found to be independent of ethnicity 
[33, 34]. In addition, within the American population 
FEV1/FVC showed less variation than other absolute 
measures of spirometric volume or flow [35]. An ELA 
reference equation generated using only one spirometric 
parameter, namely FEV1, raises concerns over the reliability 
of its predictive capacity [27]. The variability of the 
spirometry results in healthy adults shown in previous work 
has created wide variation in ELA [18]. These factors that 
are associated with the construction of the ELA reference 
equations might in part explain the discrepancy between the 
results reported in previous work and those shown in our 
results. 
5. LIMITATIONS 
Being the first study of its type in Jordan, several 
limitations were found. First, this study was not a 
longitudinal one, therefore may not reveal possible changes 
connected to age. However most of the previous published 
equations were also not based on a longitudinal study. 
Furthermore, the aim of ELA is to give a strong message for 
smokers to encourage them to quit smoking at the time point 
of examination regardless of possible future changes. 
Second, the age of the study population was positively 
skewed. However, the large sample size that was 
incorporated into the study and the diversity of the locations 
gives credibility to our results. In addition, the message for 
encouragement to quit smoking is best utilized among young 
age smokers as the earlier a participant quits smoking the 
less damage smoking will have on health: quitting smoking 
at the age of 30 increases life expectancy by 10 years while 
quitting at the age of 60 adds only 3 years to the life 
expectancy [5]. Finally, data on some potential risk factors 
were unavailable, including birthweight, indoor air pollution 
from fuel used for cooking, or outdoor air pollution 
exposure. However, the objective of this study was to 
analyze the applicability of ELA equations on the Jordanian 
population and their ability to differentiate between smokers 
and nonsmokers who were living in the same geographical 
areas. 
CONCLUSION 
In conclusion, results of this study strongly suggest that 
the existing ELA reference equations are not a reliable 
source to estimate ELA within the Jordanian population. 
New regression equations should be formulated that depend 
on a more relevant population sample and to base the 
equations on current data. Future studies should follow the 
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ATS/ERS spirometry guidelines and numerous spirometric 
parameters should be included as explanatory variables.  
LIST OF ABBREVIATIONS 
ANCOVA = Analysis of Covariance 
BMI = Body Mass Index 
COPD = Chronic Obstruction Pulmonary Disease 
ELA = Estimated Lung Age 
ERS = European Respiratory Society 
FEF = Forced Expiratory Flow 
FEV1 = Expiratory Volume in one second 
FVC = Forced Vital Capacity 
NHANES-3 = Third National Health and Nutrition 
Examination Survey 
PEFR = Peak Expiratory Flow Rate 
PFT = Pulmonary Function Test 
SPSS = Statistical Package for Social Sciences 
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APPENDIX 
Participants where approached in the following locations: 
I) Amman the capital, and the most populated city, we 
recruited 812 subjects from four sites  
1. AlZaytoonah University of Jordan which has over 
10000 students and about 1000 teaching staff from different 
areas of Jordan, Amman, Zarqa, Irbid, Madaba and Fuheis. 
2. The Al Husain Medical City, which is the largest 
medical compound in Jordan composed  of five hospitals that 
provide health care for the patients coming from different 
regions of the Kingdome (All the recruited subjects are those 
who were accompanying the patients. 
3. Zamzam polyclinic which is a large polyclinic in 
Khalda near the city center. 
4. Pharmacy one which is a chain pharmacy which has 
branches distributed all over the country, were we offered 
the service of measuring the pulmonary function tests free 
for the customers. 
II) Zarqa: The second largest city 3 sites were included  
(n= 423). 
1. Zarqa Governmental Hospital. 
2. ultan Clinic 
3. Pharmacy One. 
III) Irbid: The third largest city, two sites were included 
(n=233). 
1. Irbid specialized hospital. 
2. Zamzam polyclinic of Irbid 
IV) Madaba: one site was included (n=176) 
1. Madaba Health Center. 
V) Fuheis: the least populated city were one site was 
included (n= 123). 
1. Al-Fuheis Comprehensive Health Center  
Advertisements were placed on the internet and in places 
were participant recruitment was conducted, then a personal 
approach was used to invite people to read about the study 
and consider participation. 
 
Fig. (1). Recruitment time frame. 
Table 8. Recruits’ distribution.  
 
City Sites Population No of Subjects 
Amman 4 1,275,857 812 
Zarqa 3 792,665 423 
Irbid 2 307,480 233 
Madaba 1 82,335 176 
Fuheis 1 18916 123 
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